Qi Bai

1.5k total citations
47 papers, 924 citations indexed

About

Qi Bai is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Qi Bai has authored 47 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 22 papers in Molecular Biology. Recurrent topics in Qi Bai's work include Renal cell carcinoma treatment (31 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Renal and related cancers (15 papers). Qi Bai is often cited by papers focused on Renal cell carcinoma treatment (31 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Renal and related cancers (15 papers). Qi Bai collaborates with scholars based in China, United Kingdom and Canada. Qi Bai's co-authors include Jianming Guo, Li Liu, Yu Xia, Jiejie Xu, Ying Xiong, Yang Qu, Jiajun Wang, Zewei Wang, Yu Zhu and Qilai Long and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Qi Bai

47 papers receiving 912 citations

Peers

Qi Bai
Mengting Liao China
Ilaria Marech Italy
Li Zhou China
Futoshi Miyazono Japan
Ruochuan Zang China
David Borg Sweden
Hye Won Chung South Korea
Mihaela Chivu‐Economescu Romania
Yixiang Mao China
Pascale Soyeux France
Mengting Liao China
Qi Bai
Citations per year, relative to Qi Bai Qi Bai (= 1×) peers Mengting Liao

Countries citing papers authored by Qi Bai

Since Specialization
Citations

This map shows the geographic impact of Qi Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Bai more than expected).

Fields of papers citing papers by Qi Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Bai. The network helps show where Qi Bai may publish in the future.

Co-authorship network of co-authors of Qi Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Bai. A scholar is included among the top collaborators of Qi Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Bai. Qi Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yao, Jiaxi, Qi Bai, Yuan Huang, et al.. (2025). Artificial intelligence links CT images to pathologic features and survival outcomes of renal masses. Nature Communications. 16(1). 1425–1425. 5 indexed citations
2.
Bai, Qi, Yanting Wu, Qiongzhen Zeng, et al.. (2021). The Essential Oil of Artemisia argyi H.Lév. and Vaniot Attenuates NLRP3 Inflammasome Activation in THP-1 Cells. Frontiers in Pharmacology. 12. 712907–712907. 16 indexed citations
3.
Xi, Wei, Yingyong Hou, Xiaoyi Hu, et al.. (2021). No Detection of Pseudocapsule of Tumor-Parenchyma Interface on Multidetector Computed Tomography (MDCT) Images: Clinical Significance and Histological Reflections in Renal Cell Carcinoma. Cancer Management and Research. Volume 13. 5403–5411. 2 indexed citations
4.
Xi, Wei, Yingyong Hou, Xiaoyi Hu, et al.. (2021). Prognostic significance of pseudocapsule status in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Translational Andrology and Urology. 10(11). 4132–4141. 2 indexed citations
5.
Xiong, Ying, et al.. (2020). Development and validation of an individualized DNA repair-related gene signature in localized clear cell renal cell carcinoma. World Journal of Urology. 39(4). 1203–1210. 2 indexed citations
6.
Wang, Tao, Quan Zhou, Han Zeng, et al.. (2020). CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer. Cancer Immunology Immunotherapy. 69(9). 1855–1867. 40 indexed citations
7.
Zhou, Pengjun, Ziyao Li, Dandan Xu, et al.. (2019). Cepharanthine Hydrochloride Improves Cisplatin Chemotherapy and Enhances Immunity by Regulating Intestinal Microbes in Mice. Frontiers in Cellular and Infection Microbiology. 9. 225–225. 31 indexed citations
8.
Qi, Yangyang, Yuan Chang, Zewei Wang, et al.. (2019). Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response. Cancer Immunology Immunotherapy. 68(12). 2067–2080. 36 indexed citations
9.
Xiong, Ying, Yu Qi, Qi Bai, et al.. (2019). Relevance of arm somatic copy number alterations for oncologic outcomes and tumor immune microenvironment in clear cell renal cell carcinoma. Annals of Translational Medicine. 7(22). 646–646. 7 indexed citations
10.
Xiong, Ying, Li Liu, Yu Xia, et al.. (2019). Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma. Cancer Immunology Immunotherapy. 68(5). 731–741. 40 indexed citations
11.
Xiong, Ying, Li Liu, Qi Bai, et al.. (2019). Individualized immune-related gene signature predicts immune status and oncologic outcomes in clear cell renal cell carcinoma patients. Urologic Oncology Seminars and Original Investigations. 38(1). 7.e1–7.e8. 8 indexed citations
12.
Bai, Qi, et al.. (2018). [Mammary myofibroblastoma: a clinicopathologic analysis of nine cases].. PubMed. 47(10). 747–752. 1 indexed citations
13.
14.
Wang, Jiajun, Li Liu, Yang Qu, et al.. (2017). HLA class I expression predicts prognosis and therapeutic benefits from tyrosine kinase inhibitors in metastatic renal-cell carcinoma patients. Cancer Immunology Immunotherapy. 67(1). 79–87. 5 indexed citations
15.
Xiong, Ying, Li Liu, Yu Xia, et al.. (2017). Low CCL17 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma. BMC Cancer. 17(1). 117–117. 10 indexed citations
16.
Wang, Jiajun, Li Liu, Qilai Long, et al.. (2017). Decreased expression of JMJD3 predicts poor prognosis of patients with clear cell renal cell carcinoma. Oncology Letters. 14(2). 1550–1560. 7 indexed citations
17.
Xia, Yu, Li Liu, Qi Bai, et al.. (2016). Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma. Scientific Reports. 6(1). 32657–32657. 16 indexed citations
18.
Xi, Wei, Li Liu, Jiajun Wang, et al.. (2016). High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma. Scientific Reports. 6(1). 29177–29177. 18 indexed citations
19.
Long, Qilai, Li Liu, Yu Xia, et al.. (2015). High peritumoral Bmi-1 expression is an independent prognosticator of poor prognosis in renal cell carcinoma. Tumor Biology. 36(10). 8007–8014. 4 indexed citations
20.
Xia, Yu, Li Liu, Qilai Long, et al.. (2015). Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 34(1). 5.e1–5.e9. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mengting Liao Breakdown of academic impact, for papers by Ilaria Marech Breakdown of academic impact, for papers by Li Zhou Breakdown of academic impact, for papers by Futoshi Miyazono Breakdown of academic impact, for papers by Ruochuan Zang Breakdown of academic impact, for papers by David Borg Breakdown of academic impact, for papers by Hye Won Chung Breakdown of academic impact, for papers by Mihaela Chivu‐Economescu Breakdown of academic impact, for papers by Yixiang Mao Breakdown of academic impact, for papers by Pascale Soyeux
Rankless by CCL
2026